vs
LIVEPERSON INC(LPSN)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是LIVEPERSON INC的1.3倍($75.5M vs $59.3M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -19.0%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-12.0M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -16.6%)
LivePerson是一家全球性科技企业,专注于开发对话式商务与人工智能软件,相关产品与解决方案能够帮助企业搭建智能对话体系,优化客户沟通体验,助力企业实现数字化商务运营转型。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
LPSN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$59.3M
营收增速更快
PBYI
高出46.7%
-19.0%
自由现金流更多
PBYI
多$26.3M
$-12.0M
两年增速更快
PBYI
近两年复合增速
-16.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $59.3M | $75.5M |
| 净利润 | $-46.1M | — |
| 毛利率 | 73.2% | 69.3% |
| 营业利润率 | -68.7% | 22.7% |
| 净利率 | -77.8% | — |
| 营收同比 | -19.0% | 27.7% |
| 净利润同比 | 58.9% | — |
| 每股收益(稀释后) | $-9.22 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LPSN
PBYI
| Q4 25 | $59.3M | $75.5M | ||
| Q3 25 | $60.2M | $54.5M | ||
| Q2 25 | $59.6M | $52.4M | ||
| Q1 25 | $64.7M | $46.0M | ||
| Q4 24 | $73.2M | $59.1M | ||
| Q3 24 | $74.2M | $80.5M | ||
| Q2 24 | $79.9M | $47.1M | ||
| Q1 24 | $85.1M | $43.8M |
净利润
LPSN
PBYI
| Q4 25 | $-46.1M | — | ||
| Q3 25 | $8.7M | $8.8M | ||
| Q2 25 | $-15.7M | $5.9M | ||
| Q1 25 | $-14.1M | $3.0M | ||
| Q4 24 | $-112.1M | — | ||
| Q3 24 | $-28.3M | $20.3M | ||
| Q2 24 | $41.8M | $-4.5M | ||
| Q1 24 | $-35.6M | $-4.8M |
毛利率
LPSN
PBYI
| Q4 25 | 73.2% | 69.3% | ||
| Q3 25 | 71.4% | 77.7% | ||
| Q2 25 | 69.7% | 76.5% | ||
| Q1 25 | 71.8% | 77.1% | ||
| Q4 24 | 77.4% | 76.4% | ||
| Q3 24 | 73.1% | 63.9% | ||
| Q2 24 | 79.4% | 77.4% | ||
| Q1 24 | 71.3% | 75.5% |
营业利润率
LPSN
PBYI
| Q4 25 | -68.7% | 22.7% | ||
| Q3 25 | -24.2% | 17.6% | ||
| Q2 25 | -10.8% | 12.7% | ||
| Q1 25 | -26.2% | 8.7% | ||
| Q4 24 | -138.0% | 22.6% | ||
| Q3 24 | -21.6% | 27.4% | ||
| Q2 24 | -37.3% | -4.6% | ||
| Q1 24 | -42.7% | -5.3% |
净利率
LPSN
PBYI
| Q4 25 | -77.8% | — | ||
| Q3 25 | 14.5% | 16.2% | ||
| Q2 25 | -26.4% | 11.2% | ||
| Q1 25 | -21.8% | 6.5% | ||
| Q4 24 | -153.2% | — | ||
| Q3 24 | -38.1% | 25.2% | ||
| Q2 24 | 52.3% | -9.6% | ||
| Q1 24 | -41.8% | -11.0% |
每股收益(稀释后)
LPSN
PBYI
| Q4 25 | $-9.22 | $0.26 | ||
| Q3 25 | $-2.76 | $0.17 | ||
| Q2 25 | $-0.17 | $0.12 | ||
| Q1 25 | $-0.24 | $0.06 | ||
| Q4 24 | $-17.23 | $0.40 | ||
| Q3 24 | $-4.74 | $0.41 | ||
| Q2 24 | $-0.33 | $-0.09 | ||
| Q1 24 | $-0.40 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-44.5M | $130.3M |
| 总资产 | $454.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
LPSN
PBYI
| Q4 25 | $95.0M | $97.5M | ||
| Q3 25 | $106.7M | $94.4M | ||
| Q2 25 | $162.0M | $96.0M | ||
| Q1 25 | $176.3M | $93.2M | ||
| Q4 24 | $183.2M | $101.0M | ||
| Q3 24 | $142.1M | $96.7M | ||
| Q2 24 | $146.0M | $96.8M | ||
| Q1 24 | $127.1M | $107.2M |
总债务
LPSN
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $512.1M | $102.0M |
股东权益
LPSN
PBYI
| Q4 25 | $-44.5M | $130.3M | ||
| Q3 25 | $-22.1M | $115.3M | ||
| Q2 25 | $-82.4M | $104.7M | ||
| Q1 25 | $-74.9M | $97.1M | ||
| Q4 24 | $-67.3M | $92.1M | ||
| Q3 24 | $45.9M | $71.1M | ||
| Q2 24 | $66.6M | $48.5M | ||
| Q1 24 | $19.2M | $51.0M |
总资产
LPSN
PBYI
| Q4 25 | $454.7M | $216.3M | ||
| Q3 25 | $511.4M | $202.9M | ||
| Q2 25 | $604.2M | $194.9M | ||
| Q1 25 | $596.2M | $196.2M | ||
| Q4 24 | $607.8M | $213.3M | ||
| Q3 24 | $692.0M | $220.7M | ||
| Q2 24 | $703.8M | $205.0M | ||
| Q1 24 | $724.7M | $214.1M |
负债/权益比
LPSN
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 26.69× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-9.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | $14.4M |
| 自由现金流率自由现金流/营收 | -20.2% | 19.1% |
| 资本支出强度资本支出/营收 | 3.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.5M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
LPSN
PBYI
| Q4 25 | $-9.7M | $14.4M | ||
| Q3 25 | $-6.0M | $9.7M | ||
| Q2 25 | $-11.7M | $14.1M | ||
| Q1 25 | $-3.1M | $3.6M | ||
| Q4 24 | $-3.1M | $15.6M | ||
| Q3 24 | $4.8M | $11.0M | ||
| Q2 24 | $-17.9M | $1.0M | ||
| Q1 24 | $1.1M | $11.2M |
自由现金流
LPSN
PBYI
| Q4 25 | $-12.0M | $14.4M | ||
| Q3 25 | $-8.9M | $9.7M | ||
| Q2 25 | $-14.8M | $14.1M | ||
| Q1 25 | $-6.9M | $3.6M | ||
| Q4 24 | $-6.8M | $15.6M | ||
| Q3 24 | $-230.0K | $11.0M | ||
| Q2 24 | $-22.9M | $1.0M | ||
| Q1 24 | $-10.4M | — |
自由现金流率
LPSN
PBYI
| Q4 25 | -20.2% | 19.1% | ||
| Q3 25 | -14.8% | 17.7% | ||
| Q2 25 | -24.9% | 26.8% | ||
| Q1 25 | -10.6% | 7.7% | ||
| Q4 24 | -9.2% | 26.4% | ||
| Q3 24 | -0.3% | 13.7% | ||
| Q2 24 | -28.7% | 2.1% | ||
| Q1 24 | -12.2% | — |
资本支出强度
LPSN
PBYI
| Q4 25 | 3.9% | 0.0% | ||
| Q3 25 | 4.8% | 0.0% | ||
| Q2 25 | 5.3% | 0.0% | ||
| Q1 25 | 5.8% | 0.1% | ||
| Q4 24 | 5.0% | 0.0% | ||
| Q3 24 | 6.8% | 0.0% | ||
| Q2 24 | 6.2% | 0.0% | ||
| Q1 24 | 13.5% | 0.0% |
现金转化率
LPSN
PBYI
| Q4 25 | — | — | ||
| Q3 25 | -0.69× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
PBYI
暂无分部数据